Cargando…
Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study
BACKGROUND: In 2011, the World Health Organization began recommending glycated haemoglobin (HbA(1c)) as a measure for diagnosing type 2 diabetes (T2D). This initiative may have changed basic T2D epidemiology. Consequently, we examined time changes in T2D incidence and mortality during 1995-2018. MET...
Autores principales: | Knudsen, Jakob S., Knudsen, Signe S., Hulman, Adam, Witte, Daniel R., Gregg, Edward W., Lauritzen, Torsten, Pedersen, Lars, Sørensen, Henrik T., Thomsen, Reimar W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733171/ https://www.ncbi.nlm.nih.gov/pubmed/35024680 http://dx.doi.org/10.1016/j.lanepe.2021.100291 |
Ejemplares similares
-
Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA(1c) and glucose‐lowering drug use before and after hypoglycaemia
por: Bengtsen, Mads Bisgaard, et al.
Publicado: (2021) -
Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark
por: Nicolaisen, Sia K, et al.
Publicado: (2022) -
Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study
por: Knudsen, Jakob S., et al.
Publicado: (2020) -
Real‐world use of cardioprotective glucose‐lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
por: Funck, Kristian L., et al.
Publicado: (2020) -
Four‐year HbA1c and LDL‐cholesterol trajectories among individuals with mental disorders and newly developed type 2 diabetes
por: Kristensen, Frederik P., et al.
Publicado: (2021)